Special Issue "Cardiovascular Disease: New Generation of Biomarkers and Future Therapeutic Concepts"
Deadline for manuscript submissions: 31 August 2020.
2. Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain
3. CIBERCV, Institute of Health Carlos III, Madrid, Spain
Interests: biomarker; cardiometabolic disease; cardiovascular disease; exercise; noncoding RNA; precision medicine
2. REBIRTH Excellence Cluster, Hannover Medical School, Hannover, Germany
Interests: cardiovascular disease; cardiac regeneration; noncoding RNA therapy; telomere biology; aging
Despite the great advances in the management of cardiovascular disease, this condition persists as the most common noncommunicable disease and the leading cause of death worldwide. There is an urgent need to improve the clinical management of cardiovascular disease with regard to novel treatment concepts as well as the identification of new biomarkers. In this Special Issue, we will provide a comprehensive overview of the recent developments in cardiovascular disease, from novel tools to guide clinical decision-making, to promising next-generation therapeutic approaches.
We welcome the submission of original research and review articles on the following topics:
- Novel molecular mechanisms implicated in cardiovascular disease development;
- Recent advances in drug targets and therapeutic approaches;
- New biomarkers for diagnosis, prognosis and risk stratification;
- Prediction and monitorization of the therapeutic response;
- Drug repositioning;
- Alternative use of established clinical indicators;
- Advances in cardiovascular personalized medicine.
We encourage authors to include a section indicating the impact of the novel findings on the clinical management of the cardiovascular patient.
Dr. David de Gonzalo-Calvo
Dr. Christian Bär
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Biomarker-guided therapy
- Biomarker development and validation
- Cardiac aging
- Cardiac regeneration
- Cardiovascular disease
- Cardiovascular therapy
- Drug repositioning
- Risk stratification